Pécs

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Multiple sclerosis2 trials
• Asthma1 trial
• COPD1 trial

Phase

• Phase 32 trials
• Phase 42 trials

Status

• Completed2 trials
• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Sanofi4 trials

Running trials

• Recruiting

  A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

  NCT07053423· Phase 4· Sanofi· Source

• Active, not recruiting

  A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

  NCT06372145· Phase 3· Sanofi· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• COPD1 recruiting

Closed trials

• Completed

  EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

  NCT04998604· Phase 4· Sanofi· Source

• Completed

  Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)

  NCT04411641· Phase 3· Sanofi· Source